← Back to Search

BOOST Group for Psychosis

N/A
Waitlist Available
Led By Christopher R Bowie, PhD
Research Sponsored by Queen's University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up participants will be assessed at baseline, and assessed for changes immediately following the treatment and at 6 months and 12 months post treatment.
Awards & highlights

Study Summary

This trial looks at an intervention to help people with psychosis who also have to deal with the negative stereotypes they've internalized about their condition. The intervention is aimed at helping with self-esteem and quality of life. The proposed research would expand the program and make it available to more people.

Who is the study for?
The BOOST trial is for young adults aged 18-35 with conditions like schizophrenia or other psychotic disorders. Participants should be comfortable using computers and phones, not currently abusing substances, and able to read and speak English. Those with neurological issues, significant medical illnesses affecting brain function, physical disabilities impeding participation in the program, recent head injuries, or recent CBT treatment are excluded.Check my eligibility
What is being tested?
BOOST is a self-stigma intervention designed to reduce negative self-perceptions in individuals with psychosis. The study aims to enhance this existing program by incorporating more therapeutic techniques and virtual care options to improve its impact on self-esteem and quality of life over the long term while also reaching those in remote areas.See study design
What are the potential side effects?
As BOOST is a psychological intervention rather than a medication, it may not have typical 'side effects'. However, participants might experience emotional discomfort discussing personal experiences related to stigma during group sessions.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~participants will be assessed at baseline, and assessed for changes immediately following the treatment and at 6 months and 12 months post treatment.
This trial's timeline: 3 weeks for screening, Varies for treatment, and participants will be assessed at baseline, and assessed for changes immediately following the treatment and at 6 months and 12 months post treatment. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Internalized stigma
Secondary outcome measures
Generalized Anxiety Disorder scale (GAD-7)
Interpersonal Hopelessness Scale
Interpersonal Needs Questionnaire
+5 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Internalized stigma groupExperimental Treatment1 Intervention
BOOST is an 8 session group intervention, delivered over 4 weeks. The program uses evidence based therapeutic techniques and integrates cognitive behavioural therapy and peer support to reduce or prevent the internalization of stigma in early psychosis. Sessions 1-4 focus on dispelling stigmatizing myths about psychosis and evaluating the accuracy of group members or societies stigmatizing beliefs in order to normalize experiences associated with and reactions to the symptoms of psychosis. Sessions 5-8 teach behavioural approaches for self-empowerment through social skills training, development of assertiveness skills, and goal setting. Role-plays that are specific to young people with psychosis, which were co-developed with people with lived experience, provide opportunities to practice these skills in session. During role plays, participants monitor stigmatizing beliefs that may interfere with communication or pursuing goals.

Find a Location

Who is running the clinical trial?

Queen's UniversityLead Sponsor
365 Previous Clinical Trials
120,317 Total Patients Enrolled
2 Trials studying Psychosis
373 Patients Enrolled for Psychosis
Christopher R Bowie, PhDPrincipal InvestigatorQueen's University
1 Previous Clinical Trials
75 Total Patients Enrolled

Media Library

Self-stigma intervention Clinical Trial Eligibility Overview. Trial Name: NCT05571228 — N/A
Psychosis Research Study Groups: Internalized stigma group
Psychosis Clinical Trial 2023: Self-stigma intervention Highlights & Side Effects. Trial Name: NCT05571228 — N/A
Self-stigma intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT05571228 — N/A
Psychosis Patient Testimony for trial: Trial Name: NCT05571228 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Can I join the experimental program being conducted?

"This trial requires 100 participants aged 18-35 that have been clinically diagnosed with a psychotic disorder, such as schizophrenia or schizoaffective disorder. Furthermore, they must be competent in spoken and written English, computer skills and telephone operations; excluding those who use drugs or alcohol to excess."

Answered by AI

Is recruitment for the experiment still taking place?

"This particular medical experiment is no longer recruiting participants, having been first posted on October 1st 2020 and recently updated on the 04th of October 2022. However, 641 other clinical trials remain open to enrollees."

Answered by AI

Is the stipulated age range for this clinical trial inclusive of septuagenarians?

"This medical trial is specifically seeking participants aged 18 to 35. Those under the age of consent have 138 different studies available and adults over 65 can choose from 364 separate research efforts."

Answered by AI

Who else is applying?

What state do they live in?
Arizona
Texas
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria
How many prior treatments have patients received?
0
3+
What site did they apply to?
Queen's University

Why did patients apply to this trial?

Looking for a better solution.
PatientReceived 1 prior treatment
Recent research and studies
clinicaltrials.govStudy
Be Outspoken and Overcome Stigmatizing Thoughts (BOOST) Group for Early Psychosis
Dr. Christopher Bowie 2020. "Be Outspoken and Overcome Stigmatizing Thoughts (BOOST) Group for Early Psychosis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05571228.
All > Schizophrenia
~22 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top